News | October 07, 2023
Amgen completes acquisition of Horizon Therapeutics
Advances Amgen's mission to serve patients with rare disease medicines
Advances Amgen's mission to serve patients with rare disease medicines
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
New Board of Directors and management team at Suven Pharma also appointed
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The market capitalization of the company stood at Rs. 7,000 crore +
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Subscribe To Our Newsletter & Stay Updated
